Added to YB: 2026-09-24
Pitch date: 2026-09-18
INMD [neutral]
InMode Ltd.
-1.32%
current return
Author Info
No bio for this author
Company Info
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Market Cap
$824.8M
Pitch Price
$14.38
Price Target
11.50 (-20%)
Dividend
N/A
EV/EBITDA
4.37
P/E
11.79
EV/Sales
0.88
Sector
Health Care Equipment and Supplies
Category
value
InMode: Cheap on Cash and Earnings, but the Decline May Be Too Deep
INMD (overview): InMode’s $14.50 share price includes $8.50 of cash, leaving roughly $6 for the operating business, or about 8x estimated $0.70 EPS. A 4x multiple implies about $3, or 20%, downside, while 12x implies $2.40, or 16%, upside. Earnings appear to be declining faster than 11% annually amid heavy competition, strategy issues, repeated negative revisions, missed promises and disappointments, leaving the appropriate multiple and underlying trajectory unresolved.
Read full article (1 min)